News Coverage 09.19.19 Share on Twitter Share on Facebook Share on LinkedIn Celsius Therapeutics to Use Single-Cell Platform in Three New Immuno-Oncology Collaborations Related Announcement, Press Release Alliance Aims to Develop Next-Gen Cancer Therapies Announcement, Press Release Biomarkers May Predict Better Treatment Options Announcement, Press Release First Patients Dosed in Pancreatic Platform Trial